Liquid Biopsy for Noncoding RNA Improves Cancer Detection
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cancer |
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 17, 2023 | Cancer |
Americans have gotten at least 12 million more years of life to live due to preventive cancer screenings conducted over the past 25 years.
Read MorePosted by Andy Lundin | Jul 28, 2023 | Cancer |
A team of scientists developed a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).
Read MorePosted by Andy Lundin | Jul 25, 2023 | Cancer |
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Lung Cancer |
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More